Summit Therapeutics (SMMT) News Today $19.03 +0.84 (+4.62%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Summit Therapeutics (NASDAQ:SMMT) Trading 6.5% Higher - What's Next?Summit Therapeutics (NASDAQ:SMMT) Trading Up 6.5% - Time to Buy?January 17 at 3:53 PM | marketbeat.com24,879 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Acquired by SeaCrest Wealth Management LLCSeaCrest Wealth Management LLC acquired a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 24,879 shares of the company's stock, valued at approJanuary 17 at 3:58 AM | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading Down 6.3% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Trading Down 6.3% - What's Next?January 16 at 10:21 PM | marketbeat.comWhy Summit Therapeutics Rocketed 584% in 2024January 15 at 9:35 AM | fool.comSummit Therapeutics (NASDAQ:SMMT) Showcases Promising Data at J.P. Morgan Healthcare ConferenceJanuary 15 at 2:02 AM | americanbankingnews.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 6.3% - Time to Sell?Summit Therapeutics (NASDAQ:SMMT) Trading Down 6.3% - What's Next?January 14, 2025 | marketbeat.comTruist Securities Initiates Coverage of Summit Therapeutics (SMMT) with Buy RecommendationJanuary 9, 2025 | msn.comMerck rival Summit draws new buy from Truist on deal prospectsJanuary 8, 2025 | msn.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 3.3% - Time to Buy?Summit Therapeutics (NASDAQ:SMMT) Trading Up 3.3% - Time to Buy?January 8, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at Truist FinancialTruist Financial started coverage on Summit Therapeutics in a research note on Wednesday. They set a "buy" rating and a $35.00 price objective for the company.January 8, 2025 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Receives $33.33 Average Price Target from AnalystsJanuary 8, 2025 | americanbankingnews.comSummit Therapeutics Inc. (NASDAQ:SMMT) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSummit Therapeutics Inc. (NASDAQ:SMMT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy reJanuary 5, 2025 | marketbeat.comPrediction: These 3 Healthcare Stocks Will Soar in 2025January 4, 2025 | fool.comWhy Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now?January 1, 2025 | msn.com3 Stocks That Could Be Monster Winners in 2025December 29, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Trading Down 6.2% - Here's WhySummit Therapeutics (NASDAQ:SMMT) Stock Price Down 6.2% - Should You Sell?December 27, 2024 | marketbeat.comFranklin Resources Inc. Takes Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Franklin Resources Inc. acquired a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 103,276 shares of the company's stock, valued at approximately $December 27, 2024 | marketbeat.comIs Summit Therapeutics Inc. (SMMT) the Best Performing Biotech Stock in 2024?December 23, 2024 | insidermonkey.comGeode Capital Management LLC Has $67.90 Million Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)Geode Capital Management LLC increased its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 4.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,099,808 shares of the company's stock after purchasing an additional 13December 22, 2024 | marketbeat.comBarclays PLC Lowers Stake in Summit Therapeutics Inc. (NASDAQ:SMMT)Barclays PLC lessened its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 35.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 250,118 shares of the company's stock after sellingDecember 21, 2024 | marketbeat.comWhy These 10 Stocks Jumped YesterdayDecember 20, 2024 | insidermonkey.comWhy Did Summit Therapeutics Inc. (SMMT) Jump Yesterday?December 20, 2024 | msn.comWhere Will Summit Therapeutics Be in 5 Years?December 20, 2024 | fool.com3 Stocks That Could Turn $1,000 into $5,000 by 2030December 20, 2024 | fool.comWellington Management Group LLP Has $968,000 Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Wellington Management Group LLP lowered its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 83.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 44,188 shares of the company's stDecember 20, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading 6.8% Higher - What's Next?Summit Therapeutics (NASDAQ:SMMT) Stock Price Up 6.8% - Time to Buy?December 19, 2024 | marketbeat.com3 No-Brainer Biotech Stocks to Buy With $200 Right NowDecember 18, 2024 | fool.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by State Street CorpState Street Corp lowered its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 15.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,468,514 shares of the company's stock after seDecember 18, 2024 | marketbeat.com2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall StreetDecember 15, 2024 | fool.comInvesting $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 TodayDecember 14, 2024 | fool.comVirtu Financial LLC Acquires Shares of 42,243 Summit Therapeutics Inc. (NASDAQ:SMMT)Virtu Financial LLC bought a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 42,243 shares of the company's stock, valued at approximately $December 14, 2024 | marketbeat.comSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 13, 2024 | businesswire.comWells Fargo & Company Begins Coverage on Summit Therapeutics (NASDAQ:SMMT)Wells Fargo & Company began coverage on shares of Summit Therapeutics in a research note on Wednesday. They set an "overweight" rating and a $30.00 target price for the company.December 11, 2024 | marketbeat.com31,300 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. bought a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 31,300 shares of the company's stockDecember 7, 2024 | marketbeat.comJefferies Initiates Coverage of Summit Therapeutics (SMMT) with Buy RecommendationDecember 6, 2024 | msn.comWhy Summit Therapeutics Stock Rocketed 6% Higher on FridayDecember 6, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated at Jefferies Financial GroupJefferies Financial Group began coverage on Summit Therapeutics in a research report on Friday. They issued a "buy" rating and a $31.00 price target on the stock.December 6, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Boosts Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)The Manufacturers Life Insurance Company increased its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 43.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 295,629 shares of the company's stoDecember 6, 2024 | marketbeat.comBank of Montreal Can Buys Shares of 97,575 Summit Therapeutics Inc. (NASDAQ:SMMT)Bank of Montreal Can purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 97,575 shares of the company's stock, valued at approximately $2,038,0December 6, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Charles Schwab Investment Management Inc. increased its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 53.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,432,713 shares of the coDecember 4, 2024 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Acquired by Fmr LLCFmr LLC increased its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 9.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 8,303,119 shares of the company's stock after acquiring an additionalDecember 3, 2024 | marketbeat.comBaker BROS. Advisors LP Purchases 1,202,643 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Baker BROS. Advisors LP boosted its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 5.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,424,865 shares of the company's stock after puDecember 2, 2024 | marketbeat.comBillionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% HigherDecember 2, 2024 | fool.com99,442 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Bought by Cerity Partners LLCCerity Partners LLC bought a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 99,442 shares of the company's sDecember 2, 2024 | marketbeat.comWarning: This Skyrocketing Stock Has a Hidden RiskNovember 30, 2024 | fool.comIntech Investment Management LLC Takes $694,000 Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Intech Investment Management LLC purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 31,680 shares of the company's stock, valued at apNovember 30, 2024 | marketbeat.comSummit Therapeutics to Present at Upcoming Investor ConferencesNovember 26, 2024 | finance.yahoo.com3 Monster Stocks in the MakingNovember 23, 2024 | fool.comSummit Therapeutics' (SMMT) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $44.00 price objective on shares of Summit Therapeutics in a report on Monday.November 18, 2024 | marketbeat.comMarketBeat Week in Review – 11/4 - 11/8 (SMMT)Markets rallied strongly this week on clarity about the election and an expected rate cut, but next week's inflation readings will determine if momentum lastsNovember 9, 2024 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.710.55▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼65▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenx News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Genmab A/S News Today Viatris News Today Intra-Cellular Therapies News Today Moderna News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts